Showing 1 - 10 of 127,259
pharmaceutical company payments to 316,622 physicians across the U.S. from 2009-2011. States were classified as having strong, weak … payments in strong disclosure states was physicians' reduced willingness to accept payments rather than the imposition of … interpretation of physicians' reduced willingness to accept payments. Significant disclosure aversion reducing con- flicts of …
Persistent link: https://www.econbiz.de/10012220324
I study voluntary disclosure of oligopoly firms when they learn information from asset prices. By disclosing information, a firm incurs a cost of losing competitive advantage to its rivals but benefits from learning from a more informative asset market. Adding a financial market helps the...
Persistent link: https://www.econbiz.de/10011897851
Persistent link: https://www.econbiz.de/10010347241
So, you've decided to do a PhD ... now what? In this essay, I provide some advice for beginning PhD students - basically sharing with you what I would tell my younger self. Doing a PhD is a transformative experience, but the process is challenging - not merely on an intellectual level but also...
Persistent link: https://www.econbiz.de/10010425046
Persistent link: https://www.econbiz.de/10011717373
In the United States, rural and low-income communities have difficulty attracting and retaining physicians, potentially … adversely impacting health outcomes. With a limited supply of physicians completing medical school at US universities, foreign …-born and educated physicians provide a potential source of supply in underserved areas. For international medical school …
Persistent link: https://www.econbiz.de/10014447325
prior studies, we find that physicians updated their beliefs quickly, and do indeed adjust to new medical research …, particularly young physicians, prior to mandatory policy or professional guidelines …
Persistent link: https://www.econbiz.de/10014635619
Persistent link: https://www.econbiz.de/10015408556
Persistent link: https://www.econbiz.de/10003298546